Impact of Omicron on Lung Transplant Recipients: A Third COVID-19 Surge with Different Outcomes.
作者信息
Hum Jamie, Laothamatas Kemarut, Scheffert Jenna, Nolan Margaret, Reilly Genevieve, D'Ovidio Frank, Benvenuto Luke, Arcasoy Selim M
机构信息
Columbia University New York, New York.
New York-Presbyterian Hospital New York, New York.
出版信息
Ann Am Thorac Soc. 2023 Jan;20(1):148-151. doi: 10.1513/AnnalsATS.202205-452RL.
Abstract
摘要
相似文献
1
Impact of Omicron on Lung Transplant Recipients: A Third COVID-19 Surge with Different Outcomes.奥密克戎对肺移植受者的影响：第三次新冠疫情高峰及不同结局
Ann Am Thorac Soc. 2023 Jan;20(1):148-151. doi: 10.1513/AnnalsATS.202205-452RL.
2
COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.肾移植和肾胰联合移植受者队列中感染奥密克戎SARS-CoV-2变异株的COVID-19：临床特征、危险因素和结局
Transplantation. 2022 Sep 1;106(9):1860-1866. doi: 10.1097/TP.0000000000004203. Epub 2022 Aug 19.
3
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine.mRNA 疫苗三剂接种后移植受者对奥密克戎变异株的中和作用
Am J Transplant. 2022 Aug;22(8):2089-2093. doi: 10.1111/ajt.17020. Epub 2022 Mar 21.
4
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - Implications for the omicron variant: Correspondence.心脏移植受者六个月内对第三剂BNT162B2新冠疫苗的细胞和体液反应动力学——对奥密克戎变种的启示：通信
J Heart Lung Transplant. 2022 Nov;41(11):1649-1650. doi: 10.1016/j.healun.2022.07.012. Epub 2022 Jul 22.
5
Is the Omicron variant truly less virulent in solid organ transplant recipients?奥密克戎变异株是否确实在实体器官移植受者中毒力较弱？
Transpl Infect Dis. 2022 Dec;24(6):e13923. doi: 10.1111/tid.13923. Epub 2022 Aug 12.
6
Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.肺移植受者对第三剂基于mRNA的SARS-CoV-2疫苗的血清学反应。
Transpl Immunol. 2022 Jun;72:101599. doi: 10.1016/j.trim.2022.101599. Epub 2022 Apr 4.
7
Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety.新型冠状病毒疫苗在肺移植受者中的免疫原性、疗效和安全性。
Front Immunol. 2022 Jun 1;13:906225. doi: 10.3389/fimmu.2022.906225. eCollection 2022.
8
Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.肾移植受者在接种第三剂mRNA疫苗后对新冠病毒奥密克戎变异株的抗体反应欠佳。
Kidney Int. 2022 Jun;101(6):1282-1286. doi: 10.1016/j.kint.2022.04.009. Epub 2022 Apr 13.
9
Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.奥密克戎变异株流行期间，疫苗接种和早期单克隆抗体治疗对器官移植受者 2019 冠状病毒病结局的影响
Clin Infect Dis. 2022 Dec 19;75(12):2193-2200. doi: 10.1093/cid/ciac324.
10
Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave.奥密克戎毒株流行期间接种疫苗的实体器官移植受者中新冠病毒病的发病率和严重程度
Transplantation. 2022 Sep 1;106(9):e413-e415. doi: 10.1097/TP.0000000000004226. Epub 2022 Jun 3.
引用本文的文献
1
Incidence and severity of SARS-CoV-2 infection in lung transplant recipients in the Omicron era.奥密克戎时代肺移植受者中新型冠状病毒2型感染的发病率和严重程度。
JHLT Open. 2023 Sep 20;1:100004. doi: 10.1016/j.jhlto.2023.100004. eCollection 2023 Oct.
2
A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection.200 多名 COVID-19 感染肺移植受者的单中心经验
Transplant Direct. 2024 Aug 29;10(9):e1676. doi: 10.1097/TXD.0000000000001676. eCollection 2024 Sep.
3
COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis.奥密克戎 BA.5 疫情期间，替沙格韦单抗-西加韦单抗预先暴露预防对肺移植受者 COVID-19 结局的影响：单中心分析。
Transpl Int. 2024 Jan 24;37:12061. doi: 10.3389/ti.2024.12061. eCollection 2024.
本文引用的文献
1
Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients - implications for the omicron variant.心脏移植受者接种第三剂 BNT162B2 疫苗后 6 个月内细胞和体液反应的动力学——对奥密克戎变异株的影响。
J Heart Lung Transplant. 2022 Oct;41(10):1417-1425. doi: 10.1016/j.healun.2022.05.014. Epub 2022 May 24.
2
COVID-19 Clinical Outcomes in Solid Organ Transplant Recipients During the Omicron Surge.奥密克戎毒株激增期间实体器官移植受者的新冠病毒疾病临床结局
Transplantation. 2022 Jul 1;106(7):e346-e347. doi: 10.1097/TP.0000000000004162. Epub 2022 Apr 11.
3
One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience.疫情爆发一年之际：肺移植受者中不断演变的新冠病毒感染结局，单中心经验
Transplant Direct. 2022 Feb 21;8(3):e1296. doi: 10.1097/TXD.0000000000001296. eCollection 2022 Mar.
4
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine.mRNA 疫苗三剂接种后移植受者对奥密克戎变异株的中和作用
Am J Transplant. 2022 Aug;22(8):2089-2093. doi: 10.1111/ajt.17020. Epub 2022 Mar 21.
5
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国，2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
6
Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19.COVID-19 肺移植患者的临床特征、管理实践和结局。
J Heart Lung Transplant. 2021 Sep;40(9):936-947. doi: 10.1016/j.healun.2021.05.003. Epub 2021 May 18.
7
COVID-19 in lung transplant recipients: A single center case series from New York City.肺移植受者中的 COVID-19：来自纽约市的单中心病例系列。
Am J Transplant. 2020 Nov;20(11):3072-3080. doi: 10.1111/ajt.16241. Epub 2020 Sep 5.
8
Influenza in solid organ transplant recipients: epidemiology, management, and outcomes.实体器官移植受者中的流感：流行病学、处理和结局。
Expert Rev Anti Infect Ther. 2020 Feb;18(2):103-112. doi: 10.1080/14787210.2020.1713098. Epub 2020 Jan 18.
Zotero 插件